BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 2783323)

  • 1. Absence of induction of IL-1 production in human monocytes by complement fragments.
    Arend WP; Massoni RJ; Niemann MA; Giclas PC
    J Immunol; 1989 Jan; 142(1):173-8. PubMed ID: 2783323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor.
    Arend WP; Joslin FG; Massoni RJ
    J Immunol; 1985 Jun; 134(6):3868-75. PubMed ID: 2985700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes.
    Haeffner-Cavaillon N; Cavaillon JM; Laude M; Kazatchkine MD
    J Immunol; 1987 Aug; 139(3):794-9. PubMed ID: 3496391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of IL-1 release through stimulation of the C3b/C4b complement receptor type one (CR1, CD35) on human monocytes.
    Bacle F; Haeffner-Cavaillon N; Laude M; Couturier C; Kazatchkine MD
    J Immunol; 1990 Jan; 144(1):147-52. PubMed ID: 2136879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma.
    Okusawa S; Dinarello CA; Yancey KB; Endres S; Lawley TJ; Frank MM; Burke JF; Gelfand JA
    J Immunol; 1987 Oct; 139(8):2635-40. PubMed ID: 3116090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes.
    van Epps DE; Chenoweth DE
    J Immunol; 1984 Jun; 132(6):2862-7. PubMed ID: 6373920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1q acts synergistically with phorbol dibutyrate to activate CR1-mediated phagocytosis by human mononuclear phagocytes.
    Bobak DA; Frank MM; Tenner AJ
    Eur J Immunol; 1988 Dec; 18(12):2001-7. PubMed ID: 2975599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human C5a modulates monocyte Fc and C3 receptor expression.
    Yancey KB; O'Shea J; Chused T; Brown E; Takahashi T; Frank MM; Lawley TJ
    J Immunol; 1985 Jul; 135(1):465-70. PubMed ID: 3158706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of the intracellular killing of Staphylococcus aureus by monocytes: regulation by immunoglobulin G and complement components C3/C3b and B/Bb.
    Leijh PC; van den Barselaar MT; Daha MR; van Furth R
    J Immunol; 1982 Jul; 129(1):332-7. PubMed ID: 6979568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ba fragment of complement factor B inhibits human B lymphocyte proliferation.
    Ambrus JL; Peters MG; Fauci AS; Brown EJ
    J Immunol; 1990 Mar; 144(5):1549-53. PubMed ID: 2307833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monocyte spreading induced by factor Bb of the alternative pathway of complement activation. A possible role for C5 in monocyte spreading.
    Sundsmo JS; Götze O
    J Exp Med; 1981 Sep; 154(3):763-77. PubMed ID: 6912276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human C5a induces transcription but not translation of interleukin 1 beta mRNA in human monocytes.
    Geiger T; Rordorf C; Galakatos N; Seligmann B; Henn R; Lazdins J; Erard F; Vosbeck K
    Lymphokine Cytokine Res; 1992 Feb; 11(1):55-63. PubMed ID: 1576247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ
    J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new apoptotic pathway for the complement factor B-derived fragment Bb.
    Uwai M; Terui Y; Mishima Y; Tomizuka H; Ikeda M; Itoh T; Mori M; Ueda M; Inoue R; Yamada M; Hayasawa H; Horiuchi T; Niho Y; Matsumoto M; Ishizaka Y; Ikeda K; Ozawa K; Hatake K
    J Cell Physiol; 2000 Nov; 185(2):280-92. PubMed ID: 11025450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ; Das C; Bennett D; Terman DS
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
    Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
    Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1q inhibits the expression of B lymphoblastoid cell line interleukin 1 (IL 1).
    Habicht GS; Beck G; Ghebrehiwet B
    J Immunol; 1987 Apr; 138(8):2593-7. PubMed ID: 3494080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.
    Marder SR; Chenoweth DE; Goldstein IM; Perez HD
    J Immunol; 1985 May; 134(5):3325-31. PubMed ID: 3884709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.